Skip to main content

Head and Neck Cancer News (Page 3)

Related terms: Oral Cancer

Teikoku Pharma USA, Inc. Announces FDA Approval of Docetaxel Injection, Non-Alcohol Formula

San Jose, Calif. - December 28, 2015 - Teikoku Pharma USA (TPU) announced today that the U.S. Food and Drug Administration ("FDA") has approved Docetaxel Injection, Non-Alcohol Formula ("Docetaxel...

FDA Approves Erbitux to Treat Late-stage Head and Neck Cancer

SILVER SPRING, Md., Nov. 7, 2011 /PRNewswire-USNewswire/ – The U.S. Food and Drug Administration today approved Erbitux (cetuximab) for use with chemotherapy to treat patients with late-stage...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Cancer

Related drug support groups

methotrexate, Keytruda, Opdivo